PPIF and diabetes mellitus: These findings also suggest that the opening of the MPT pore is one of the triggers of mitochondrial damage in the skeletal muscles in diabetes mellitus, and targeting cyclophilin D and the MPT pore by alisporivir is a therapeutic approach to prevent the development of mitochondrial dysfunction and the associated oxidative stress in the skeletal muscles in diabetes.